Benefits of RAS Antagonist Use in Heart Failure and Severe Renal Insufficiency | Journal Scan

Study Questions:

What is the association of renin–angiotensin receptor (RAS) antagonist therapy and mortality in patients with heart failure with reduced ejection fraction (HFrEF) and severe renal insufficiency?